Detailed ExplanationNLE · Neurosensory NursingReal content

NLE Neurosensory Nursing — Seizure, Infectious, and Degenerative Neurologic DisordersDetailed Explanation

Summary Concepts Notes Revision Deep Dive Slides Flashcards Mistakes Cheat Mnemonics Templates

The Seizure, Infectious, and Degenerative Neurologic Disorders chapter rewards slow, careful thinking over quick pattern matching, especially on Professional Regulation Commission (PRC) — Board of Nursing's scenario-based NLE items. This detailed explanation walks through the full derivation of every core idea, then links each one to a worked example pulled from recent NLE Neurosensory Nursing papers.

Exam context

The Philippine Nurse Licensure Examination (PNLE) is conducted by Professional Regulation Commission (PRC) — Board of Nursing and is scheduled for Bi-annual. The Neurosensory Nursing subtest is marked as "Core" in the official pattern, and Seizure, Infectious, and Degenerative Neurologic Disorders appears in position 3rd of 5 in the NLE Neurosensory Nursing review rotation. Passing mark: 75% weighted average with no sub-test below 60%. Recent NLE 2026 papers have drawn roughly 50 questions from this subject.

Seizure, Infectious, and Degenerative Neurologic Disorders - Detailed Explanation

This chapter covers some of the most heavily tested neurologic conditions in the Philippine Nursing Licensure Examination (NLE). As a BSN graduate preparing for the PRC Board Exam, you must be able to recognize clinical presentations, prioritize nursing interventions using Maslow's Hierarchy of Needs and the nursing process, differentiate between similar emergency conditions, and apply safe and effective pharmacologic knowledge. The disorders covered here — seizures, status epilepticus, CNS infections, Parkinson's disease, multiple sclerosis, ALS, myasthenia gravis, Guillain-Barré syndrome, and Alzheimer's disease — all require you to think critically under pressure. Many NLE questions are scenario-based, asking you to identify the priority action, the most appropriate nursing diagnosis, or the correct medication response. Under RA 9173 (Philippine Nursing Act of 2002), nurses are accountable for safe, competent, and ethical care — this includes recognizing neurologic emergencies and acting promptly within your scope of practice. Master this chapter and you will be well-equipped to answer 10–15% of NLE neurosensory questions correctly.

Concepts

Seizures and Epilepsy

A seizure is a sudden, abnormal, excessive electrical discharge from neurons in the brain. Think of it like a sudden electrical surge in the brain's wiring. Epilepsy is a chronic neurologic disorder defined by recurrent, unprovoked seizures — having one seizure does not automatically mean a person has epilepsy. Seizures are classified into two major categories: 1. GENERALIZED SEIZURES — both hemispheres are involved from the start, and consciousness is lost. - Tonic-Clonic (Grand Mal): The most classic and most tested type. It has three phases: (a) Aura — a warning sensation before the seizure (visual, auditory, or a 'funny feeling'); (b) Ictal Phase — the actual seizure, beginning with the TONIC phase (body stiffening, jaw clenching, possible cyanosis) lasting 10–20 seconds, followed by the CLONIC phase (rhythmic jerking of extremities) lasting 1–2 minutes; (c) Postictal Phase — confusion, drowsiness, headache, amnesia lasting minutes to hours. The patient may be incontinent. - Absence (Petit Mal): Brief (5–30 second) staring spells with loss of awareness. Common in children. The child may appear to be daydreaming and then resume normal activity. No postictal phase. 2. FOCAL (PARTIAL) SEIZURES — begin in one area of the brain. - Focal Aware (Simple Partial): Consciousness is preserved. The patient may experience motor, sensory, or autonomic symptoms. - Focal Impaired Awareness (Complex Partial): Consciousness is impaired. May involve automatisms (lip smacking, hand rubbing). NURSING PRIORITY DURING A SEIZURE (Maslow: Safety and Security): The FIRST priority is AIRWAY and SAFETY. The nurse's job during an active seizure is to PROTECT, not to stop the seizure physically. Key actions during a seizure: - EASE the patient to the floor or bed to prevent falls - TURN the patient to the LATERAL (side-lying) position — this is the most critical action to prevent aspiration of secretions - LOOSEN tight clothing around the neck - PROTECT the head with padding - NEVER restrain the patient — this can cause fractures or dislocations - NEVER insert anything into the mouth — doing so can break teeth or obstruct the airway. This is a common NLE trap! - TIME the seizure from start to finish - OBSERVE and document: eye movements, progression, incontinence, body parts involved, duration - STAY with the patient throughout After the seizure (postictal phase): - Keep the patient in lateral position - Reorient the patient calmly - Allow rest - Assess for injuries (tongue biting, bruises) - Document findings NANDA Nursing Diagnoses for Seizures: - Risk for Injury related to seizure activity - Risk for Aspiration related to loss of consciousness and impaired swallowing reflex - Ineffective Airway Clearance related to increased secretions and loss of protective reflexes - Deficient Knowledge regarding seizure management and medication adherence

Examples

Using Maslow's hierarchy, physiologic safety (airway and injury prevention) is the top priority. The lateral position prevents aspiration — a life-threatening complication. This is a classic NLE scenario testing what the nurse should do FIRST.

Scenario

A 24-year-old patient in the medical ward suddenly falls to the floor and begins jerking all four extremities. The nurse arrives at the bedside.

Solution

The priority action is to protect the patient from injury and maintain airway patency: ease the patient to a safe position on the floor (if not already on a bed), turn to the lateral position, loosen any tight clothing, protect the head, and time the seizure. Do NOT restrain. Do NOT put anything in the mouth. Stay with the patient and call for help.

This tests conceptual understanding and debunks a common nursing misconception. The NLE often tests this through scenario questions that include 'insert padded tongue blade' as a distracter.

Scenario

A student nurse asks why they should NOT insert a tongue blade into the mouth of a seizing patient. How would you explain this?

Solution

Inserting a tongue blade or any object into the mouth of a seizing patient is DANGEROUS and CONTRAINDICATED. During the tonic phase, the jaw muscles are clenched — forcing an object in can break teeth, lacerate the gums, and cause airway obstruction if the object breaks. The myth that patients can 'swallow their tongue' is false — the tongue cannot be swallowed. Aspiration is prevented by turning the patient to the side.

Applications

Seizure precautions in hospital settings: padded side rails, oxygen and suction at bedside, IV access maintained
Community health teaching: medication adherence, driving restrictions (per LTFRB guidelines in the Philippines), avoiding alcohol
School health: recognizing absence seizures in school-age children and appropriate first aid
Postoperative neurosurgery nursing: monitoring for new-onset seizures as a sign of increased ICP

Misconceptions

MYTH: You should hold down the patient to stop the shaking. FACT: Never restrain — this causes fractures. You cannot stop the electrical discharge by restraint.
MYTH: Insert a spoon or tongue blade to prevent the patient from swallowing their tongue. FACT: The tongue CANNOT be swallowed. Inserting objects causes more harm.
MYTH: All seizures mean the patient has epilepsy. FACT: A single seizure from a fever (febrile seizure) or metabolic cause is not epilepsy. Epilepsy requires recurrent, unprovoked seizures.
MYTH: After a seizure, the patient should be made to sit up immediately. FACT: Keep in lateral position during postictal phase to protect the airway.
MYTH: Absence seizures are dangerous and require immediate hospitalization always. FACT: They are generally benign short spells but do require medical evaluation and management.

Related Concepts

Status Epilepticus
Antiseizure Pharmacology (Phenytoin, Carbamazepine, Valproic Acid)
Increased Intracranial Pressure (ICP)
Airway Management
Fall Prevention and Safety

Common Exam Questions

Example

A patient begins having a generalized tonic-clonic seizure in the hallway. What is the nurse's priority action? Answer: Ease the patient to the floor and turn to the lateral position.

Approach

Use Maslow's hierarchy: Airway > Breathing > Circulation > Safety. The first action is always to protect the airway and prevent injury. Lateral position is the key action to prevent aspiration.

Question Type

Priority Action (What should the nurse do FIRST?)

Example

Which action by the nurse during a seizure requires correction? A) Turning the patient to the side B) Loosening tight clothing C) Inserting a padded tongue blade D) Timing the seizure. Answer: C — inserting anything in the mouth is contraindicated.

Approach

Look for the action that would CAUSE harm — restraining the patient and inserting objects in the mouth are the two most commonly tested contraindications during seizures.

Question Type

What should the nurse NOT do? (Contraindicated action)

Example

A child repeatedly has 10-second episodes of staring and then resumes normal activity with no memory of the event. This is most consistent with which seizure type? Answer: Absence (Petit Mal) seizure.

Approach

Know the hallmark features of each seizure type: tonic-clonic (stiffening then jerking, postictal confusion), absence (brief staring, no postictal phase), focal aware (consciousness preserved).

Question Type

Classification/Recognition

Key Points To Remember

Tonic-clonic seizure has TONIC phase (stiffening) THEN CLONIC phase (jerking) — remember the order
Absence seizures have NO postictal phase — the patient resumes normal activity immediately
The FIRST nursing action during a seizure is to PROTECT the patient and maintain AIRWAY
NEVER put anything in the mouth — this includes airways, tongue blades, or fingers
NEVER restrain a seizing patient — this causes injury
TURN the patient to the SIDE (lateral position) to prevent aspiration
TIME the seizure — duration is critical for deciding if it becomes status epilepticus
DOCUMENT: type of movements, body parts affected, duration, eye deviation, incontinence
Epilepsy requires TWO or more unprovoked seizures for diagnosis
Aura precedes some generalized seizures and can serve as a warning signal

Status Epilepticus

Status epilepticus (SE) is defined as a continuous seizure lasting 5 minutes or more, OR two or more seizures between which the patient does NOT regain consciousness. It is a NEUROLOGIC EMERGENCY — one of the most critical situations you will encounter as a nurse. Why is it dangerous? Prolonged seizing causes: - Hypoxia and hypoxic brain injury (neurons are starved of oxygen) - Hyperthermia (massive muscle contractions generate heat) - Metabolic acidosis - Hypoglycemia (glucose is depleted by intense muscle activity) - Rhabdomyolysis - Death if untreated The 5-minute threshold is important: if a seizure has lasted 5 minutes, it is unlikely to stop on its own and MUST be treated immediately. PRIORITY MANAGEMENT SEQUENCE (ABCDs of Status Epilepticus): STEP 1 — AIRWAY & OXYGENATION: Position lateral, suction secretions, apply supplemental oxygen via face mask, prepare for intubation if needed. STEP 2 — IV ACCESS & MONITORING: Establish IV line, attach cardiac monitor, pulse oximeter, check blood pressure. STEP 3 — LABORATORY: Draw blood for glucose, electrolytes, CBC, antiseizure drug levels, toxicology screening. Treat hypoglycemia with dextrose (D50W) if present. STEP 4 — FIRST-LINE PHARMACOTHERAPY: Administer IV BENZODIAZEPINES immediately: - Lorazepam (Ativan) IV — preferred first-line in hospital settings: 0.1 mg/kg IV, slower onset but longer duration - Diazepam (Valium) IV — also first-line: 0.15–0.2 mg/kg IV, faster but shorter acting - If NO IV access: diazepam rectal gel (Diastat) or midazolam IM/intranasal STEP 5 — SECOND-LINE: If benzodiazepines fail to stop the seizure, give a loading dose of a longer-acting antiseizure drug: - Phenytoin or Fosphenytoin (preferred because less irritating to veins) - Levetiracetam (Keppra) — increasingly used; fewer drug interactions - Valproic acid IV STEP 6 — REFRACTORY STATUS EPILEPTICUS: If seizures continue despite above, patient may need general anesthesia (propofol, midazolam infusion, pentobarbital coma) in ICU with continuous EEG monitoring. SIDE EFFECTS TO MONITOR during treatment: - Benzodiazepines → respiratory depression and sedation (have flumazenil ready? — Note: flumazenil reverses benzodiazepines but is not routinely used in SE) - Phenytoin IV → hypotension, cardiac dysrhythmias (give slowly, no faster than 50 mg/min, in NORMAL SALINE only) NANDA Nursing Diagnoses: - Ineffective Airway Clearance - Risk for Aspiration - Risk for Injury (neurologic, metabolic) - Decreased Intracranial Adaptive Capacity

Examples

The 7-minute duration exceeds the 5-minute threshold for status epilepticus. The nurse must act as part of the emergency team, administering life-saving medications and supporting ABCs. This tests prioritization and pharmacologic knowledge — core NLE competencies.

Scenario

A patient with known epilepsy has been observed seizing for 7 minutes. He has not regained consciousness. What should the nurse do?

Solution

This is status epilepticus. Priority actions: (1) Call for help and alert the physician immediately. (2) Maintain lateral airway position and apply oxygen. (3) Ensure IV access is patent. (4) Prepare and administer IV lorazepam or diazepam as ordered. (5) Monitor vital signs, SpO2, and neurologic status. (6) Check blood glucose.

This tests pharmacologic safety knowledge — a critical nursing responsibility under RA 9173. Nurses must verify drug compatibility before administration.

Scenario

The physician orders IV phenytoin for a patient in status epilepticus. The only available IV fluid is D5W. What should the nurse do?

Solution

Do NOT mix or infuse phenytoin in D5W (dextrose solutions). Phenytoin PRECIPITATES (forms crystals) in dextrose solutions, rendering it ineffective and potentially occluding the IV line. Request and use NORMAL SALINE (0.9% NaCl) as the diluent. Inform the physician if normal saline is not immediately available.

Applications

Emergency department triage: immediate identification of status epilepticus and activation of the emergency response
ICU nursing: continuous EEG monitoring, management of refractory status epilepticus with anesthetic agents
Community: teaching caregivers to call emergency services (911) if a seizure lasts longer than 5 minutes
Pediatric settings: febrile status epilepticus management and teaching fever control to parents

Misconceptions

MYTH: You should wait to see if the seizure stops on its own before treating. FACT: At 5 minutes, intervention is required — waiting risks severe brain damage.
MYTH: Diazepam (Valium) given rectally is not a valid route in emergencies. FACT: Rectal diazepam gel (Diastat) is a valid prehospital/emergency option when IV access is unavailable.
MYTH: Phenytoin can be mixed with any IV fluid. FACT: Phenytoin precipitates in dextrose — only normal saline is compatible.
MYTH: Once the seizure stops, the emergency is over. FACT: Post-ictal monitoring is essential — airway, breathing, and neurologic status must continue to be assessed.

Related Concepts

Seizures and Epilepsy
Phenytoin Pharmacology
Airway Management
Benzodiazepine Pharmacology
Neurologic Emergencies

Common Exam Questions

Example

A patient's seizure has lasted 8 minutes. After ensuring airway, what medication does the nurse prepare first? Answer: IV lorazepam or diazepam (benzodiazepine).

Approach

Always start with AIRWAY. Then medication. The first drug given is always a BENZODIAZEPINE IV.

Question Type

Emergency Priority (What is the nurse's immediate action?)

Example

Phenytoin is ordered IV. In which solution should it be diluted? Answer: Normal saline (0.9% NaCl) only.

Approach

Know the incompatibility: phenytoin + dextrose = precipitate. Know the rate: phenytoin no faster than 50 mg/min. Know monitoring: BP and cardiac rhythm.

Question Type

Pharmacologic Safety

Example

Status epilepticus is defined as a seizure lasting at least how many minutes? Answer: 5 minutes.

Approach

Memorize: 5 minutes = status epilepticus. This is often tested as a single-item knowledge question.

Question Type

Definition/Time Threshold

Key Points To Remember

Status epilepticus = seizure lasting 5 MINUTES OR MORE, or repeated seizures without regaining consciousness
It is a MEDICAL EMERGENCY — prolonged seizures cause irreversible brain injury
FIRST-LINE treatment: IV BENZODIAZEPINES (lorazepam or diazepam)
SECOND-LINE: Phenytoin, fosphenytoin, or levetiracetam IV
Always check and treat BLOOD GLUCOSE — hypoglycemia can cause or worsen seizures
Phenytoin IV must be given in NORMAL SALINE only — precipitates in dextrose solutions
Monitor for respiratory depression when giving benzodiazepines
Continuous monitoring: SpO2, cardiac rhythm, blood pressure, neurologic status
Airway protection is the NUMBER ONE priority in any seizure emergency

Antiseizure Pharmacology

Antiseizure (anticonvulsant) medications are used for long-term control of epilepsy and acute management of seizures. Understanding their mechanisms, side effects, nursing considerations, and patient teaching is essential for the NLE. KEY ANTISEIZURE DRUGS AND NURSING CONSIDERATIONS: 1. PHENYTOIN (Dilantin) - Mechanism: Stabilizes neuronal membranes by blocking sodium channels - Indications: Tonic-clonic seizures, focal seizures, status epilepticus (IV) - Therapeutic serum level: 10–20 mcg/mL (levels below → breakthrough seizures; levels above → toxicity) - IV Route Rules: * Administer in NORMAL SALINE ONLY (precipitates in dextrose) * Maximum rate: NO FASTER than 50 mg/min (rapid infusion → hypotension, bradycardia, cardiac arrest) * Must monitor blood pressure and cardiac rhythm during infusion - Side Effects: * GINGIVAL HYPERPLASIA (gum overgrowth) — teach meticulous oral hygiene (brushing, flossing, regular dental visits) * Nystagmus (early toxicity sign), ataxia, diplopia (increasing toxicity) * Hirsutism (excessive hair growth), coarsening of facial features (long-term) * Hepatotoxicity — monitor liver function tests * Drug interactions: many (enzyme inducer — affects warfarin, oral contraceptives) * Teratogenic — category D; causes fetal hydantoin syndrome - Patient Teaching: * NEVER stop phenytoin abruptly — risk of STATUS EPILEPTICUS * Consistent dosing at the same time daily * Wear medical identification (MedicAlert bracelet) * Avoid alcohol * Report signs of toxicity (slurred speech, unsteady gait, diplopia) 2. CARBAMAZEPINE (Tegretol) - Indications: Focal seizures, tonic-clonic, trigeminal neuralgia - Key Concern: Can cause AGRANULOCYTOSIS and APLASTIC ANEMIA — monitor CBC regularly - Also causes hepatotoxicity — monitor LFTs - Drug of choice for trigeminal neuralgia 3. VALPROIC ACID (Depakene/Depakote) - Broad-spectrum: used for many seizure types including absence seizures - Monitoring: HEPATOTOXICITY (monitor liver enzymes, especially in first 6 months) and THROMBOCYTOPENIA (monitor platelet count) - Teratogenic: neural tube defects — avoid or use contraception in women of childbearing age - Weight gain is a common side effect 4. LEVETIRACETAM (Keppra) - Broad-spectrum, increasingly used - Advantages: fewer drug interactions, can be given IV - Notable side effect: behavioral changes — irritability, agitation, depression 5. LAMOTRIGINE (Lamictal) - Risk of STEVENS-JOHNSON SYNDROME (SJS) — a severe, potentially fatal skin reaction (blistering rash) - Teach patients to report any rash immediately - Start at low doses and titrate slowly to reduce SJS risk 6. BENZODIAZEPINES (Lorazepam, Diazepam, Clonazepam) - Acute seizure termination (lorazepam, diazepam) - Long-term: clonazepam for absence and myoclonic seizures - Side effects: sedation, respiratory depression, tolerance and dependence with long-term use GENERAL PATIENT TEACHING FOR ALL ANTISEIZURE DRUGS: - NEVER stop medication abruptly — can precipitate status epilepticus - Take medications at the same time every day - Do not skip doses - Avoid alcohol (lowers seizure threshold and interacts with drugs) - Wear a medical alert identification - Maintain regular follow-up and serum drug level monitoring - Discuss family planning (many antiseizure drugs are teratogenic) - Know local regulations about driving (in the Philippines, DOTr/LTFRB guidelines apply)

Examples

Gingival hyperplasia is one of the most heavily tested phenytoin side effects in the NLE. The nurse's role is health education and referral — not to discontinue the drug without orders.

Scenario

A patient on long-term phenytoin therapy visits the outpatient clinic. On inspection, you notice that their gums appear enlarged and are growing over their teeth. What nursing intervention is appropriate?

Solution

This is gingival hyperplasia, a known side effect of phenytoin. The nurse should: (1) Reassure the patient that this is a known side effect of the medication. (2) Teach and reinforce meticulous oral hygiene: gentle brushing after every meal, flossing daily, and using a soft-bristled toothbrush. (3) Refer to a dentist for regular dental checkups. (4) Do NOT advise stopping phenytoin without physician consultation.

SJS associated with lamotrigine is a critical safety concern. Any rash appearing during lamotrigine therapy must be taken seriously. This tests drug safety knowledge and priority action under emergency conditions.

Scenario

A patient taking lamotrigine calls the nurse and reports the development of a spreading red rash with blisters on their chest and back. What is the priority action?

Solution

This presentation is consistent with Stevens-Johnson Syndrome (SJS), a potentially life-threatening hypersensitivity reaction. Priority actions: (1) Advise the patient to STOP lamotrigine immediately and seek emergency care. (2) Notify the physician immediately. (3) The patient requires urgent dermatologic and possibly ICU care.

Applications

Drug level monitoring: ensuring therapeutic range compliance and detecting toxicity early
Medication reconciliation: checking interactions (phenytoin interacts with warfarin, oral contraceptives, many other drugs)
Reproductive counseling for women with epilepsy who wish to become pregnant
Community health education: proper storage and consistent use of antiseizure medications

Misconceptions

MYTH: If seizures stop, the patient can discontinue antiseizure medications. FACT: Abrupt withdrawal triggers status epilepticus — always taper under physician guidance.
MYTH: Phenytoin can be given in any IV fluid for convenience. FACT: Only normal saline — dextrose solutions cause precipitation.
MYTH: Gingival hyperplasia from phenytoin is harmless and needs no intervention. FACT: It can lead to infections and dental problems — meticulous oral hygiene is essential.
MYTH: Lamotrigine rash is always mild. FACT: Rash may indicate Stevens-Johnson Syndrome, which can be fatal — always report and evaluate.

Related Concepts

Status Epilepticus
Seizures and Epilepsy
Pharmacokinetics and Drug Monitoring
Patient and Family Education
Medication Safety (RA 9173)

Common Exam Questions

Example

When administering IV phenytoin, which finding requires the nurse to STOP the infusion immediately? Answer: Bradycardia or significant hypotension.

Approach

Know: phenytoin → normal saline, slow rate (≤50 mg/min), monitor cardiac rhythm and BP.

Question Type

Drug Safety (IV Administration Rule)

Example

A patient on phenytoin reports that their dentist noticed unusual gum growth. The nurse recognizes this as which side effect? Answer: Gingival hyperplasia.

Approach

Associate each drug with its signature side effect: phenytoin = gingival hyperplasia; lamotrigine = SJS rash; carbamazepine = blood dyscrasias; valproic acid = hepatotoxicity.

Question Type

Side Effect Recognition

Example

Which patient statement about phenytoin requires further teaching? 'I will stop my medication if I feel better for 6 months.' Answer: This statement is incorrect — stopping abruptly risks status epilepticus.

Approach

Any question about what to teach a patient on antiseizure drugs should include: never stop abruptly, consistent timing, monitor levels, avoid alcohol, wear medical ID.

Question Type

Patient Teaching

Key Points To Remember

Phenytoin therapeutic level: 10–20 mcg/mL — memorize this range
Phenytoin IV: Normal saline ONLY, rate NO FASTER than 50 mg/min
Phenytoin causes GINGIVAL HYPERPLASIA — teach oral hygiene
NEVER stop antiseizure drugs abruptly — triggers status epilepticus
Carbamazepine: monitor CBC (agranulocytosis risk)
Valproic acid: monitor LIVER FUNCTION and PLATELET COUNT
Lamotrigine: risk of STEVENS-JOHNSON SYNDROME — report rash immediately
Levetiracetam: watch for behavioral changes (irritability, mood changes)
All antiseizure drugs require consistent dosing and regular serum level monitoring
Phenytoin and valproic acid are TERATOGENIC — use contraception or discuss family planning

Meningitis

Meningitis is inflammation of the meninges — the three protective membranes (dura mater, arachnoid mater, and pia mater) that surround the brain and spinal cord. It is most commonly bacterial or viral, and bacterial meningitis is a life-threatening emergency. COMMON CAUSATIVE ORGANISMS: - Neisseria meningitidis (meningococcus): Associated with a classic petechial/purpuric rash; can cause epidemic outbreaks; most common in college dormitories - Streptococcus pneumoniae (pneumococcus): Most common cause in adults; associated with high mortality - Haemophilus influenzae type b (Hib): Rare since Hib vaccine introduced - Listeria monocytogenes: In immunocompromised, elderly, neonates - Viral (aseptic) meningitis: Caused by enteroviruses, herpes simplex; less severe than bacterial CLASSIC TRIAD OF BACTERIAL MENINGITIS: 1. FEVER (high grade, sudden onset) 2. SEVERE HEADACHE (worst headache of life) 3. NUCHAL RIGIDITY (stiff neck — inability to flex the neck forward painlessly) ADDITIONAL MANIFESTATIONS: - Photophobia (light sensitivity) - Phonophobia (noise sensitivity) - Altered level of consciousness (restlessness → confusion → coma) - Seizures - Vomiting - Petechial/purpuric rash — CLASSIC for meningococcal meningitis; indicates septicemia (Waterhouse-Friderichsen syndrome = adrenal hemorrhage from meningococcal sepsis) TWO CLASSIC CLINICAL SIGNS (heavily tested on NLE): 1. KERNIG'S SIGN: - How to test: Patient lies supine. Flex the hip and knee to 90°. Then try to EXTEND the knee. - Positive: PAIN and RESISTANCE when extending the knee (the patient resists and the leg cannot be straightened) - Memory tip: 'Kernig = Knee cannot extend' 2. BRUDZINSKI'S SIGN: - How to test: Patient lies supine. Flex the NECK forward (passively lift the head toward the chest). - Positive: Involuntary FLEXION of the HIPS and KNEES - Memory tip: 'Brudzinski = Bottom flexes when the head moves' (neck flexion → knee flexion) DIAGNOSTIC: LUMBAR PUNCTURE (Spinal Tap) CSF Analysis distinguishes bacterial from viral meningitis: BACTERIAL meningitis CSF: - Appearance: CLOUDY/turbid (pus) - Pressure: HIGH (elevated) - WBC: HIGH — predominantly NEUTROPHILS (PMNs) - Protein: HIGH (normal is 15–45 mg/dL; bacterial = very high) - Glucose: LOW (bacteria consume glucose; normal CSF glucose = 60–70% of blood glucose) VIRAL meningitis CSF: - Appearance: CLEAR - Pressure: Normal or slightly elevated - WBC: Elevated but predominantly LYMPHOCYTES - Protein: Normal or mildly elevated - Glucose: NORMAL Memory tip for bacterial: 'CLOUDY, HIGH neutrophils, HIGH protein, LOW glucose' NURSING MANAGEMENT: PRIORITY 1 — INFECTION CONTROL: - Place on DROPLET PRECAUTIONS immediately for bacterial meningitis (especially meningococcal and Haemophilus) - Private room or cohorting; surgical mask for nurse within 1 meter; patient wears mask during transport - Maintain droplet precautions for at least 24 hours AFTER effective antibiotic treatment has been initiated - CONTACT tracing: close contacts (household, roommates) receive chemoprophylaxis with RIFAMPICIN or CIPROFLOXACIN PRIORITY 2 — ANTIBIOTIC ADMINISTRATION: - DO NOT DELAY ANTIBIOTICS waiting for CSF culture results — start EMPIRIC IV ANTIBIOTICS IMMEDIATELY - In suspected bacterial meningitis, delay in antibiotics = increased mortality - Common empiric choice: Cephalosporins (ceftriaxone) ± ampicillin ± vancomycin - CORTICOSTEROIDS (dexamethasone) are given BEFORE or WITH the first dose of antibiotic to reduce inflammation and complications (especially hearing loss) PRIORITY 3 — ICP MANAGEMENT: - HOB at 30° (semi-Fowler's) to promote venous drainage - Quiet, darkened room (reduces photophobia and stimulation that increases ICP) - Limit suctioning (causes ICP spikes) - Fluid management - Monitor neurologic status frequently (Glasgow Coma Scale) PRIORITY 4 — COMFORT AND SUPPORTIVE CARE: - Analgesics for headache - Antipyretics for fever - Seizure precautions - Isolation until antibiotics effective NANDA Nursing Diagnoses: - Risk for Infection Transmission related to bacterial meningitis - Acute Pain (headache) related to meningeal inflammation - Risk for Ineffective Cerebral Tissue Perfusion related to increased ICP - Hyperthermia related to infectious process - Disturbed Sensory Perception related to photophobia and phonophobia

Examples

This is a classic NLE scenario. The petechial rash is the hallmark of meningococcal disease. Infection control (droplet precautions) and immediate antibiotic administration are the top priorities. Delay in antibiotics significantly increases mortality.

Scenario

A 20-year-old college student is admitted with sudden-onset severe headache, high fever of 39.5°C, neck stiffness, and a widespread petechial rash. What is the priority nursing action?

Solution

Priority actions: (1) Place the patient on DROPLET PRECAUTIONS immediately. (2) Notify the physician for STAT blood cultures and LP. (3) Prepare and administer IV antibiotics as soon as ordered — do NOT delay. (4) Administer dexamethasone as ordered before or with the first antibiotic dose. (5) Dim lights, reduce noise, elevate HOB 30°. (6) Monitor neurologic status closely. The petechial rash indicates possible meningococcal septicemia, which is a life-threatening emergency.

These two signs are classic physical examination findings for meningeal irritation. They are almost always tested on the NLE as either 'which test is described' or 'what is the correct technique.'

Scenario

The nurse is about to perform Kernig's and Brudzinski's tests on a patient with suspected meningitis. How are these tests performed and what constitutes a positive result?

Solution

KERNIG'S TEST: Flex the patient's hip and knee to 90°. Attempt to extend the knee. Positive = patient resists extension and experiences pain — the knee 'won't straighten.' BRUDZINSKI'S TEST: Place the patient supine, hands under the occiput. Passively flex the neck (bring chin toward chest). Positive = the patient's hips and knees automatically flex upward. Both positive signs indicate meningeal irritation.

Applications

School health nursing: mass screening after a diagnosed case of meningococcal meningitis in a school
Public health: reporting meningococcal meningitis to local health authorities (DOH, LGU health office) as a notifiable disease under the Philippine Integrated Disease Surveillance and Response system (PIDSR)
Vaccination advocacy: meningococcal and pneumococcal vaccines in the Philippine Expanded Program on Immunization (EPI)
Emergency nursing: rapid assessment and triage of patients presenting with fever, headache, and stiff neck

Misconceptions

MYTH: You should wait for CSF culture results before starting antibiotics. FACT: In suspected bacterial meningitis, antibiotic treatment must begin IMMEDIATELY — delay increases mortality and brain damage.
MYTH: Kernig's sign involves flexing the neck. FACT: Kernig's involves the HIP and KNEE (hip flexed, knee extended). Brudzinski's involves the NECK.
MYTH: Viral and bacterial meningitis are managed the same way. FACT: Bacterial meningitis requires urgent IV antibiotics and isolation; viral is largely supportive.
MYTH: A petechial rash is always benign. FACT: In the setting of fever and meningeal signs, petechiae indicate meningococcal septicemia — a life-threatening emergency.

Related Concepts

Encephalitis
Increased Intracranial Pressure
Lumbar Puncture Procedure
Infection Control Precautions
Philippine Notifiable Disease Reporting (PIDSR)

Common Exam Questions

Example

When the nurse flexes the patient's neck and the patient spontaneously flexes both knees, this is a positive what? Answer: Brudzinski's sign.

Approach

Know the classic triad and the two meningeal signs (Kernig's and Brudzinski's). Questions often describe the technique and ask you to name the sign.

Question Type

Sign/Symptom Recognition

Example

Lumbar puncture results show cloudy CSF, glucose of 25 mg/dL, protein of 200 mg/dL, and 90% neutrophils. This is most consistent with which type of meningitis? Answer: Bacterial meningitis.

Approach

Compare bacterial vs viral: bacterial = cloudy, high protein, LOW glucose, neutrophils. Viral = clear, normal glucose, lymphocytes.

Question Type

CSF Interpretation

Example

What type of isolation is required for a patient with meningococcal meningitis? Answer: Droplet precautions.

Approach

Bacterial meningitis = DROPLET precautions. Not airborne (no N95 needed), not contact-only.

Question Type

Isolation Precautions

Key Points To Remember

Classic Triad: FEVER + SEVERE HEADACHE + NUCHAL RIGIDITY
Kernig's sign: resist knee extension when hip is flexed (knee cannot straighten)
Brudzinski's sign: neck flexion → involuntary knee and hip flexion
PETECHIAL RASH = meningococcal meningitis = EMERGENCY (septicemia risk)
Bacterial CSF: CLOUDY, HIGH neutrophils, HIGH protein, LOW glucose
Viral CSF: CLEAR, lymphocytes, normal glucose
Start ANTIBIOTICS IMMEDIATELY — do NOT wait for culture results in bacterial meningitis
DROPLET PRECAUTIONS until 24 hours after effective antibiotic treatment
Give DEXAMETHASONE before or with first antibiotic dose to reduce complications
Quiet, dim room for comfort and ICP management
Close contacts receive prophylactic antibiotics (rifampicin or ciprofloxacin)

Encephalitis

Encephalitis is inflammation of the brain parenchyma (brain tissue itself), as opposed to meningitis which affects the meninges. It is most commonly caused by viral infection and presents more severely than meningitis because the brain tissue itself is infected. COMMON CAUSES: - Herpes Simplex Virus (HSV-1): Most common cause of SPORADIC (non-epidemic) encephalitis worldwide; primarily affects the TEMPORAL LOBES; very high mortality if untreated - Arboviruses (arthropod-borne viruses): Transmitted by mosquitoes; important in the Philippines: * Japanese Encephalitis Virus (JEV): Transmitted by Culex mosquitoes; endemic in many parts of Asia including the Philippines; preventable by vaccine * Dengue-associated encephalitis * Rabies: Transmitted by infected animal bites; also causes encephalitis; fatal without post-exposure prophylaxis - Other causes: Autoimmune encephalitis (anti-NMDA receptor antibodies), bacterial, parasitic CLINICAL PRESENTATION: Encephalitis presents similarly to meningitis but with prominent BRAIN DYSFUNCTION: - Fever - Severe headache - ALTERED MENTAL STATUS — confusion, agitation, disorientation (distinguishes encephalitis from meningitis) - Personality and behavioral changes (especially with HSV temporal lobe involvement) - SEIZURES — more prominent than in meningitis - Focal neurologic deficits (weakness, aphasia, visual changes) - Hallucinations - Coma in severe cases Note: Nuchal rigidity and meningeal signs may also be present if meningeal involvement coexists (meningoencephalitis) DIAGNOSIS: - Lumbar puncture: CSF shows lymphocytic pleocytosis, elevated protein, normal glucose (similar to viral meningitis pattern) - MRI brain: Best imaging for encephalitis; shows temporal lobe involvement in HSV - PCR of CSF: Confirmatory for HSV encephalitis — detects viral DNA - EEG: May show temporal lobe abnormalities in HSV encephalitis MANAGEMENT: - HSV Encephalitis: IV ACYCLOVIR — this is the SPECIFIC ANTIVIRAL treatment; must be started EARLY (delay significantly worsens outcomes). Dose: 10 mg/kg every 8 hours for 14–21 days. Monitor for nephrotoxicity (ensure adequate hydration). - Arboviral encephalitis (Japanese Encephalitis): NO specific antiviral treatment; care is SUPPORTIVE — seizure control, ICP management, fever management, mechanical ventilation if needed - Rabies encephalitis: POST-EXPOSURE PROPHYLAXIS (PEP) with rabies immunoglobulin + rabies vaccine series BEFORE symptoms appear; once symptoms develop, rabies is virtually 100% fatal NURSING MANAGEMENT: - Monitor neurologic status continuously (LOC, Glasgow Coma Scale, pupils) - ICP management (HOB 30°, quiet environment, minimize stimulation) - Seizure precautions (padded rails, suction, oxygen at bedside) - Infection control: standard precautions (viral encephalitis is generally not transmitted person-to-person; Japanese Encephalitis requires mosquito control, not droplet precautions) - Supportive: nutrition, skin integrity, preventing immobility complications PREVENTION (important in Philippine context): - Japanese Encephalitis vaccine: Available in the Philippines; recommended for those living in or traveling to endemic areas - Vector control: Mosquito control programs, use of insect repellents, bed nets - Animal bite management: Immediate wound washing, PEP for rabies-prone bites - ABTC (Animal Bite Treatment Centers) in the Philippines are DOH-accredited centers providing PEP

Examples

This is a high-yield NLE scenario. HSV encephalitis is THE most tested cause of sporadic encephalitis. The temporal lobe presentation (behavioral changes, hallucinations, memory problems) + acyclovir = the classic answer combination.

Scenario

A 30-year-old is admitted with fever, severe headache, and bizarre behavioral changes including auditory hallucinations and aggression. MRI shows temporal lobe hemorrhagic lesions. What is the most likely diagnosis and immediate treatment?

Solution

This presentation is classic for Herpes Simplex Encephalitis (HSV encephalitis). The temporal lobe involvement and behavioral changes (personality, hallucinations) are hallmarks. The immediate treatment is IV ACYCLOVIR — do not wait for PCR confirmation; empiric acyclovir must be started immediately as delay significantly increases mortality and disability.

This scenario contextualizes encephalitis in the Philippine public health setting, where arboviral encephalitis is a real community threat. It tests both clinical and community health nursing competencies.

Scenario

A child in a rural Mindanao community is brought to the rural health unit with fever, seizures, and decreasing level of consciousness. The community has recently reported increased mosquito activity. What condition should be suspected and what is the role of the public health nurse?

Solution

Japanese Encephalitis should be suspected. Role of the public health nurse: (1) Immediately refer to a higher-level facility for diagnosis and supportive care. (2) Report the case to the local health office (PIDSR surveillance). (3) Coordinate with the DOH for vector control measures (fogging, elimination of mosquito breeding sites). (4) Conduct community education on mosquito prevention. (5) Advocate for Japanese Encephalitis vaccination in endemic areas.

Applications

Emergency nursing: recognizing altered mental status + fever as possible encephalitis and initiating workup
Community health: rabies prevention education and guiding victims of animal bites to ABTCs
Epidemiology: surveillance and reporting of Japanese Encephalitis outbreaks to DOH
ICU nursing: managing encephalitis complications (seizures, respiratory failure, increased ICP)

Misconceptions

MYTH: Encephalitis and meningitis are the same condition. FACT: Meningitis affects the meninges; encephalitis affects brain tissue itself. Encephalitis is associated with more prominent brain dysfunction.
MYTH: Once a person bitten by a rabid animal develops symptoms, treatment can still prevent death. FACT: Once clinical rabies symptoms appear, the disease is almost universally fatal. PEP must begin before symptoms develop.
MYTH: Japanese Encephalitis cannot be prevented. FACT: An effective vaccine exists and is available in the Philippines.
MYTH: Acyclovir can wait until PCR confirms HSV. FACT: Acyclovir must be started EMPIRICALLY without waiting for confirmation — delay worsens outcomes dramatically.

Related Concepts

Meningitis
Increased Intracranial Pressure
Viral Pharmacology (Acyclovir)
Philippine Public Health Surveillance (PIDSR)
Rabies Post-Exposure Prophylaxis

Common Exam Questions

Example

A patient is diagnosed with herpes simplex encephalitis. Which medication is the priority to administer? Answer: IV Acyclovir.

Approach

HSV encephalitis = IV acyclovir. This is a direct knowledge question — always appear as the answer when HSV encephalitis is the scenario.

Question Type

Drug of Choice

Example

A patient with fever and headache is now showing personality changes and hallucinations. This finding most suggests involvement of what structure? Answer: Brain parenchyma (encephalitis rather than simple meningitis).

Approach

Encephalitis = brain tissue involved = altered mental status, personality changes, seizures more prominent. Meningitis = meninges = headache, nuchal rigidity, photophobia predominate.

Question Type

Differentiation (Encephalitis vs Meningitis)

Example

A nurse is counseling a family after their child was bitten by a stray dog. What is the priority action to prevent rabies encephalitis? Answer: Immediate wound washing and referral to an Animal Bite Treatment Center (ABTC) for post-exposure prophylaxis.

Approach

Japanese Encephalitis in Philippine context — vaccine, mosquito control, reporting. Rabies — PEP, wound washing, ABTC referral.

Question Type

Prevention and Public Health

Key Points To Remember

Encephalitis = inflammation of BRAIN TISSUE; meningitis = inflammation of MENINGES
Key distinction: encephalitis has prominent ALTERED MENTAL STATUS and personality changes
HSV encephalitis: affects TEMPORAL LOBES; treat with IV ACYCLOVIR immediately
Japanese Encephalitis: arbovirus, transmitted by Culex mosquito; important in Philippines; vaccine-preventable
Rabies: virtually 100% fatal once symptoms appear — PEP BEFORE symptoms is the only option
CSF in viral encephalitis: lymphocytes, elevated protein, NORMAL glucose
MRI + CSF PCR are the best diagnostic tools for HSV encephalitis
No specific antivirals for most arboviral encephalitis — care is supportive
Monitor for seizures, increased ICP, and respiratory failure
Hydrate well when giving acyclovir to prevent nephrotoxicity

Parkinson's Disease

Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the loss of DOPAMINE-producing neurons in the SUBSTANTIA NIGRA, a region in the basal ganglia of the midbrain. This creates an imbalance: dopamine is reduced, while acetylcholine becomes relatively excess. This imbalance disrupts smooth, controlled movement. Path to remembering: The substantia nigra is literally the 'black substance' — it appears black due to the pigment neuromelanin in dopamine neurons. In Parkinson's, this region degenerates. CLASSIC CLINICAL TRIAD (TRAP mnemonic works for PD features): 1. TREMOR — Resting tremor; present at REST and disappears with intentional movement; 'pill-rolling' appearance (thumb and fingers rub together); most visible in the hands 2. RIGIDITY — Cogwheel rigidity: jerky, ratchet-like resistance when the limb is passively moved; lead-pipe rigidity: constant resistance throughout the range of motion 3. AKINESIA/BRADYKINESIA — Slowness of movement; difficulty initiating movement; problems with fine motor tasks 4. POSTURAL INSTABILITY — 4th feature; impaired balance and righting reflexes; contributes to falls ADDITIONAL MANIFESTATIONS: - Shuffling, festinating gait: short shuffling steps with increasingly rapid pace as if trying to catch the center of gravity; difficulty stopping - Masked facies (hypomimia): reduced facial expression, fixed blank stare - Micrographia: progressively smaller, cramped handwriting - Stooped (flexed) posture - Monotone, low-volume voice (hypophonia) - Dysphagia and drooling (late stage) - Seborrhea (oily skin) - Autonomic dysfunction: orthostatic hypotension, constipation, urinary problems - Depression and anxiety (very common non-motor features) - Dementia (in advanced stages — Lewy body dementia overlap) - Sleep disturbances Note: Unlike many other dementias, in Parkinson's the COGNITIVE symptoms appear late, after motor symptoms have been established for years. PHARMACOLOGY: 1. LEVODOPA-CARBIDOPA (Sinemet) — CORNERSTONE of PD treatment - Levodopa crosses the blood-brain barrier (BBB) and is converted to DOPAMINE in the brain - Carbidopa: an enzyme inhibitor that prevents levodopa from being broken down PERIPHERALLY (outside the brain), allowing more levodopa to reach the brain and reducing peripheral side effects - Side effects: * Nausea and vomiting (especially early) * ORTHOSTATIC HYPOTENSION — teach to change positions slowly * DYSKINESIAS: involuntary abnormal movements from excess dopamine stimulation (a long-term complication) * 'ON-OFF' phenomenon: unpredictable fluctuations between good motor control ('ON') and return of symptoms ('OFF') after years of therapy * 'Wearing-off' effect: medication works well but wears off before the next dose; controlled by adjusting dosing schedule - Drug-Food Interaction: HIGH-PROTEIN MEALS interfere with levodopa absorption (protein competes with levodopa for absorption in the intestine) — take on empty stomach or with low-protein foods; maintain consistent meal timing - NEVER give levodopa with MAO-A inhibitors (risk of hypertensive crisis) 2. DOPAMINE AGONISTS: Pramipexole (Mirapex), Ropinirole (Requip) - Directly stimulate dopamine receptors; used early in disease or as adjunct - Side effects: Nausea, orthostatic hypotension, impulse control disorders (compulsive gambling, eating, shopping) 3. MAO-B INHIBITORS: Selegiline (Eldepryl), Rasagiline - Inhibit the enzyme that breaks down dopamine; extend its effect - Can delay need for levodopa in early disease 4. COMT INHIBITORS: Entacapone (Comtan) - Inhibit catechol-O-methyltransferase, another enzyme that degrades levodopa/dopamine - Used to extend the effect of levodopa and reduce 'wearing-off' 5. ANTICHOLINERGICS: Benztropine (Cogentin), Trihexyphenidyl - Block acetylcholine to restore dopamine-acetylcholine balance - Primarily used for TREMOR control - Side effects: ANTICHOLINERGIC effects — dry mouth, urinary retention, constipation, blurred vision, confusion (use with caution in elderly) - NOT recommended in elderly patients with cognitive impairment 6. AMANTADINE: antiviral with some dopaminergic and anticholinergic effects; used for dyskinesias NURSING CARE PRIORITIES: - FALL PREVENTION: assess fall risk, remove hazards, provide non-slip footwear, assistive devices - MOBILITY: encourage ambulation with physical therapy, ROM exercises, gait training; teach to walk with wide stance, lift feet (not shuffle), use a metronome or visual cues on floor - NUTRITION: small, frequent, soft, easy-to-swallow meals; high-fiber diet for constipation; thickened liquids if dysphagia present; monitor weight - COMMUNICATION: allow extra time to speak; referral to speech therapist - ACTIVITY OF DAILY LIVING SUPPORT: allow independence, use adaptive equipment - MEDICATION TIMING: give medications on schedule — missed doses worsen motor function - FALL RISK EDUCATION: orthostatic hypotension (change positions slowly, dangle legs before standing) - EMOTIONAL SUPPORT: depression is common; therapeutic communication and referral SURGICAL OPTION: - Deep Brain Stimulation (DBS): electrodes implanted in the subthalamic nucleus or globus pallidus that deliver electrical pulses; used for advanced PD with medication-refractory symptoms

Examples

The wearing-off phenomenon is a predictable complication that requires physician-guided medication adjustment. The nurse's role is assessment, documentation, reporting, and patient education.

Scenario

A 68-year-old patient with Parkinson's disease is taking levodopa-carbidopa. He reports that his medication seems to 'wear off' before his next scheduled dose, causing return of tremors and stiffness. What should the nurse recommend?

Solution

This describes the 'wearing-off' effect, a common long-term complication of levodopa therapy. The nurse should: (1) Document the timing and pattern of symptom recurrence. (2) Report to the physician for medication adjustment (more frequent dosing, adding a COMT inhibitor like entacapone, or adding a dopamine agonist). (3) Ensure medication is taken on schedule — never skip or delay doses. (4) Advise avoiding high-protein meals close to medication time.

Dietary management in Parkinson's directly affects medication effectiveness and quality of life. This is a comprehensive nursing care question testing both pharmacology and nutritional knowledge.

Scenario

The nurse is creating a meal plan for a patient on levodopa-carbidopa. What dietary considerations must be included?

Solution

Key dietary considerations: (1) Avoid HIGH-PROTEIN MEALS at the same time as levodopa — protein competes with levodopa for intestinal absorption, reducing its effectiveness. Distribute protein evenly throughout the day or take levodopa 30–60 minutes before meals. (2) High-FIBER diet to prevent constipation (a common problem in PD). (3) Adequate FLUIDS for hydration and constipation prevention. (4) Small, frequent, SOFT meals if dysphagia is present. (5) Thickened liquids if swallowing is impaired.

Applications

Rehabilitation nursing: fall prevention programs, gait training with physiotherapy
Home health nursing: home safety assessment, adaptive equipment recommendations
Medication management: timing doses, monitoring for side effects, managing on-off phenomenon
Caregiver education: teaching families about disease progression and daily care strategies

Misconceptions

MYTH: The tremor in Parkinson's is worst when the patient is trying to use the hand. FACT: Parkinson's tremor is a RESTING tremor — it is MOST prominent at rest and DECREASES with intentional movement (unlike essential tremor, which worsens with movement).
MYTH: Carbidopa treats Parkinson's directly. FACT: Carbidopa only prevents PERIPHERAL breakdown of levodopa — it has no therapeutic effect on its own. It allows more levodopa to reach the brain.
MYTH: Parkinson's only causes physical symptoms. FACT: Depression, anxiety, cognitive changes, sleep disorders, and autonomic dysfunction are all non-motor features that significantly affect quality of life.
MYTH: High-protein meals are healthy and should be encouraged in all patients. FACT: In Parkinson's patients on levodopa, high-protein meals interfere with drug absorption and should be timed carefully.

Related Concepts

Neurodegeneration
Dopamine Neurotransmitter System
Fall Prevention
Swallowing and Aspiration Risk
Alzheimer's Disease (comparison — different dementia mechanism)

Common Exam Questions

Example

Which nursing diagnosis takes priority for a patient with Parkinson's disease? Answer: Risk for Injury related to postural instability and tremor.

Approach

In Parkinson's, safety is the priority due to postural instability and fall risk. 'Risk for Injury related to postural instability and tremors' is typically the priority NANDA diagnosis.

Question Type

Priority Nursing Diagnosis

Example

A patient taking levodopa-carbidopa asks what foods to avoid. The nurse should advise limiting intake of which food group at the time of medication? Answer: High-protein foods (meat, dairy).

Approach

Know that HIGH-PROTEIN MEALS interfere with levodopa absorption. This appears frequently as a dietary teaching question.

Question Type

Pharmacology and Drug-Food Interaction

Example

A patient exhibits a resting hand tremor that resembles the motion of rolling a pill between the thumb and fingers. This is characteristic of which disorder? Answer: Parkinson's disease.

Approach

Be able to identify resting tremor (pill-rolling), cogwheel rigidity, and festinating gait as Parkinson's hallmarks.

Question Type

Sign/Symptom Recognition

Key Points To Remember

Parkinson's = loss of DOPAMINE neurons in the SUBSTANTIA NIGRA
Classic triad: TREMOR (resting, pill-rolling) + RIGIDITY (cogwheel) + BRADYKINESIA
4th feature: POSTURAL INSTABILITY (leads to falls)
Levodopa-Carbidopa: carbidopa prevents peripheral breakdown of levodopa
Avoid HIGH-PROTEIN MEALS with levodopa — protein interferes with absorption
Orthostatic hypotension: a major side effect; change positions slowly
Dyskinesias (involuntary movements) are a long-term complication of levodopa
Anticholinergics used for TREMOR — watch for anticholinergic side effects in elderly
Fall prevention is a PRIORITY nursing intervention in Parkinson's
DBS (Deep Brain Stimulation) is a surgical option for advanced Parkinson's
Masked facies, micrographia, festinating gait are classic motor features

Multiple Sclerosis

Multiple sclerosis (MS) is a chronic autoimmune disorder in which the body's own immune system attacks and destroys the MYELIN SHEATH of neurons in the CENTRAL NERVOUS SYSTEM (brain, spinal cord, and optic nerves). Demyelination disrupts nerve signal conduction — messages slow down, become distorted, or fail to reach their destination. Key distinguishing feature: MS affects the CNS (brain and spinal cord), while Guillain-Barré Syndrome (GBS) affects the PERIPHERAL NERVOUS SYSTEM (outside the brain and spinal cord). This distinction is heavily tested. EPIDEMIOLOGY: - Most commonly affects YOUNG TO MIDDLE-AGED ADULTS (20–40 years) - More common in WOMEN than men (2:1 ratio) - More prevalent in temperate climates; less common in the Philippines (tropical climate) but cases do occur - Exact cause unknown but involves genetic susceptibility + environmental triggers + immune dysregulation CLINICAL COURSE (Types): - RELAPSING-REMITTING MS (RRMS) — Most common (85% of cases); episodes of acute worsening (relapses/exacerbations) followed by periods of partial or complete recovery (remissions) - Progressive MS: Secondary progressive, primary progressive — fewer remissions, gradual worsening CLINICAL MANIFESTATIONS (highly variable — 'the great mimicker'): Because MS can affect any part of the CNS, symptoms vary widely depending on where demyelination occurs: 1. FATIGUE — The MOST COMMON and MOST DISABLING symptom; a crushing, overwhelming tiredness unrelated to physical exertion; often worsens with heat (Uhthoff's phenomenon) 2. VISUAL DISTURBANCES: - OPTIC NEURITIS: inflammation of the optic nerve → painful vision loss in one eye; first symptom in many patients; vision usually partially recovers - Diplopia (double vision) from internuclear ophthalmoplegia - Nystagmus 3. MOTOR: Weakness of limbs, spasticity (muscle stiffness and spasms), difficulty walking, drop foot 4. SENSORY: Paresthesia (numbness, tingling), Lhermitte's sign — an electric-shock sensation shooting down the spine when the neck is flexed forward 5. CEREBELLAR/COORDINATION: Ataxia, intention tremor, scanning dysarthria (slow, slurred speech with irregular rhythm) 6. BLADDER DYSFUNCTION: Urgency, frequency, incontinence, or retention (neurogenic bladder) 7. COGNITIVE: Memory problems, slowed thinking, 'MS fog' 8. SEXUAL DYSFUNCTION 9. DEPRESSION Uhthoff's Phenomenon: temporary worsening of MS symptoms with increase in body temperature (hot weather, fever, exercise, hot baths). Symptoms return to baseline when temperature normalizes. DIAGNOSIS: - MRI of brain and spinal cord: Shows DEMYELINATING PLAQUES (white matter lesions); most sensitive and specific test; 'dissemination in space and time' criteria - CSF Analysis: May show elevated protein, oligoclonal bands (IgG), and mildly elevated WBC (lymphocytes) - Visual Evoked Potentials: Test optic nerve function; slowed conduction confirms demyelination MANAGEMENT: ACUTE RELAPSES: - High-dose IV CORTICOSTEROIDS (methylprednisolone) — reduce inflammation and shorten relapse duration; do not prevent long-term disability DISEASE-MODIFYING THERAPIES (prevent relapses and slow progression): - INTERFERON BETA (Avonex, Betaseron, Rebif) — injectable; reduces relapse frequency - GLATIRAMER ACETATE (Copaxone) — injectable; mechanism not fully understood; modulates immune response - Oral agents: Fingolimod, dimethyl fumarate, teriflunomide - Infusion agents: Natalizumab, ocrelizumab (for more aggressive MS) SYMPTOM MANAGEMENT: - Spasticity: Baclofen, benzodiazepines, physical therapy - Bladder dysfunction: Anticholinergics, scheduled voiding, intermittent catheterization - Fatigue: Amantadine, energy conservation strategies - Depression: Antidepressants and counseling NURSING CARE: - TRIGGER AVOIDANCE (crucial patient teaching): * HEAT: Avoid hot baths, hot weather, high fevers — heat worsens symptoms (Uhthoff's); use cooling strategies (air conditioning, cool baths, cooling vests) * STRESS: Physical and emotional stress can trigger relapses * INFECTION: Infections (especially UTIs and respiratory) are common relapse triggers; prevent with good hygiene and vaccination - ENERGY CONSERVATION: Plan activities for times of least fatigue; alternate activity and rest; prioritize tasks - FALL PREVENTION: Assess gait, use assistive devices, home safety modifications - BLADDER CARE: Scheduled voiding, avoid caffeinated beverages, perineal hygiene - SKIN INTEGRITY: Risk of pressure injury if mobility severely impaired - PSYCHOSOCIAL SUPPORT: Cope with chronic, unpredictable disease; support groups, counseling NANDA Nursing Diagnoses: - Fatigue related to demyelination and disease process - Impaired Physical Mobility related to muscle weakness and spasticity - Urinary Incontinence/Retention related to neurogenic bladder - Disturbed Sensory Perception related to demyelinating lesions - Risk for Injury related to ataxia and muscle weakness

Examples

Uhthoff's phenomenon is frequently tested on the NLE as patient education content. The nurse must explain the mechanism simply and provide practical cooling strategies.

Scenario

A 28-year-old woman with relapsing-remitting MS asks why her symptoms get worse in hot weather and return to normal when she cools down. How does the nurse explain this?

Solution

This is called the Uhthoff's phenomenon. In MS, the myelin sheath is damaged. Myelin normally insulates nerve fibers and helps conduct electrical signals efficiently. Elevated body temperature further impairs the ability of already-damaged (demyelinated) nerve fibers to conduct signals, causing a temporary worsening of symptoms. When the temperature returns to normal, signal conduction partially recovers and symptoms improve. This is a temporary phenomenon, NOT a true relapse. Teach the patient to avoid hot environments, hot baths, and to use cooling strategies (cool shower, air conditioning, cooling vest).

Fatigue management is a core nursing intervention in MS. This scenario tests the nurse's ability to holistically address the most disabling symptom of MS.

Scenario

A patient with MS reports feeling extremely tired even after sleeping 10 hours. She says, 'I can't do anything anymore — I was able to work before, but now I can't even shower without resting.' How does the nurse address MS-related fatigue?

Solution

MS-related fatigue is different from normal tiredness. Nursing interventions: (1) Validate the patient's experience — MS fatigue is real and debilitating. (2) Teach ENERGY CONSERVATION: plan high-priority activities in the morning when energy is highest, rest before and after demanding tasks, use adaptive equipment to reduce effort. (3) Collaborate with an occupational therapist. (4) Teach to maintain a cool environment — heat worsens fatigue. (5) Encourage regular low-intensity exercise (swimming is ideal — in cool water). (6) Discuss medications with the physician (amantadine may help MS fatigue).

Applications

Rehabilitation nursing: physical and occupational therapy for maximizing function during remission
Community nursing: supporting MS patients in workplace accommodations and independent living
Home health: teaching energy conservation, fall prevention, and UTI prevention
Medication management: teaching injection technique for interferon beta or glatiramer acetate

Misconceptions

MYTH: MS affects the peripheral nervous system (nerves outside the brain/spinal cord). FACT: MS affects the CENTRAL nervous system — brain, spinal cord, optic nerves. GBS affects the peripheral nerves.
MYTH: Exercise should be completely avoided in MS to prevent fatigue. FACT: Light to moderate exercise (especially swimming in cool water) is BENEFICIAL for MS — it maintains strength and reduces fatigue. Only HEAT should be avoided.
MYTH: MS always causes dementia. FACT: Cognitive changes can occur, but many MS patients maintain normal cognition, especially in early disease.
MYTH: Optic neuritis always causes permanent blindness. FACT: Most patients with optic neuritis recover significant vision after the episode — it is often temporary.

Related Concepts

Guillain-Barré Syndrome (peripheral vs central demyelination comparison)
Myasthenia Gravis (another autoimmune neuromuscular condition)
Autoimmune Disorders
Corticosteroid Therapy
Neurologic Rehabilitation

Common Exam Questions

Example

Which symptom is most commonly reported by patients with multiple sclerosis? Answer: Fatigue.

Approach

The most common symptom of MS is fatigue. Questions may ask about the 'most common,' 'most disabling,' or 'earliest' symptom.

Question Type

Symptom Identification/Priority

Example

Which activity should the nurse advise a patient with MS to avoid? A) Swimming in a cool pool B) Taking hot baths C) Light walking in the morning D) Rest periods during the day. Answer: B — hot baths cause Uhthoff's phenomenon.

Approach

Teach to avoid HEAT, STRESS, and INFECTION. Heat questions are the most frequently tested trigger for MS exacerbation.

Question Type

Patient Teaching — Trigger Avoidance

Example

A patient with MS has a sudden worsening of symptoms (relapse). The nurse anticipates which medication? Answer: IV methylprednisolone (corticosteroid).

Approach

Distinguish: ACUTE relapse = IV corticosteroids. LONG-TERM prevention of relapses = interferon beta, glatiramer acetate, or other disease-modifying therapies.

Question Type

Disease-Modifying vs Acute Relapse Treatment

Key Points To Remember

MS = autoimmune DEMYELINATION of the CNS (not peripheral nervous system)
Most common in YOUNG WOMEN (20–40 years old)
Most common course: RELAPSING-REMITTING
FATIGUE is the most common and most disabling symptom
OPTIC NEURITIS (painful vision loss) is often the FIRST symptom
AVOID HEAT — Uhthoff's phenomenon: heat worsens symptoms temporarily
AVOID STRESS and INFECTION — these trigger relapses
Lhermitte's sign: electric shock sensation down the spine when the neck flexes
MRI is the best diagnostic tool — shows demyelinating plaques
Acute relapses treated with IV CORTICOSTEROIDS (methylprednisolone)
Disease-modifying therapies: interferon beta, glatiramer acetate
ENERGY CONSERVATION is a key nursing strategy for fatigue management

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease (named after a famous American baseball player who died of the disease), is a progressive, fatal neurodegenerative disorder that affects MOTOR NEURONS — both the upper motor neurons (in the brain and corticospinal tracts) and lower motor neurons (in the brainstem and spinal cord). 'Amyotrophic' means without muscle nourishment — muscles waste away. 'Lateral sclerosis' refers to scarring (sclerosis) in the lateral columns of the spinal cord where the corticospinal tracts run. CRITICAL FEATURE: In ALS, ONLY motor neurons are affected. Sensory neurons, cognitive function (in most cases), and eye movement control are PRESERVED until very late in the disease. This is a classic NLE-tested point. PATHOPHYSIOLOGY: - Upper motor neuron degeneration → spasticity, hyperreflexia - Lower motor neuron degeneration → flaccid weakness, atrophy, fasciculations (muscle twitching visible under the skin) - Combination of BOTH UMN and LMN signs is characteristic of ALS CLINICAL MANIFESTATIONS: - Progressive muscle WEAKNESS beginning in one region, then spreading - Muscle ATROPHY (wasting) - FASCICULATIONS (visible muscle twitching) — a hallmark sign of lower motor neuron involvement - SPASTICITY and hyperreflexia (upper motor neuron signs) - DYSPHAGIA (difficulty swallowing) → aspiration risk - DYSARTHRIA (slurred, poorly articulated speech) → difficulty communicating - DYSPNEA as respiratory muscles weaken → eventual RESPIRATORY FAILURE — the cause of death in most ALS patients - Emotional lability (pseudobulbar affect): uncontrolled laughing or crying - COGNITION IS PRESERVED in most patients (except ALS-FTD variant) - EYE MOVEMENTS are preserved until very late - BLADDER AND BOWEL FUNCTION are typically preserved - SENSATION IS PRESERVED — the patient feels everything but cannot move DIAGNOSIS: - Electromyography (EMG) and nerve conduction studies: shows denervation - MRI: rules out structural causes - El Escorial criteria: diagnostic criteria based on UMN and LMN findings in different body regions MANAGEMENT: There is NO CURE for ALS. Management is SUPPORTIVE and aimed at prolonging quality life and comfort. PHARMACOLOGY: - RILUZOLE (Rilutek): The only FDA-approved drug proven to MODESTLY SLOW PROGRESSION of ALS; mechanism involves reducing glutamate-mediated neuronal death; extends survival by approximately 2–3 months; does not reverse damage - EDARAVONE (Radicava): Approved for ALS; antioxidant; slows functional decline in some patients NURSING CARE (Palliative and Supportive Focus): 1. RESPIRATORY MONITORING — HIGHEST PRIORITY: - Monitor respiratory function closely: tidal volume, vital capacity, SpO2 - Progressive respiratory muscle weakness leads to respiratory failure - Non-invasive ventilation (BiPAP) initially; progresses to tracheostomy and mechanical ventilation - Cough assist devices, suction for secretion management - ADVANCE CARE PLANNING: discuss ventilator preferences early (before the patient cannot communicate) 2. NUTRITION AND SWALLOWING: - Dysphagia → aspiration risk - Speech therapy evaluation for swallowing - Modified texture diet, thickened liquids - Percutaneous endoscopic gastrostomy (PEG) tube when swallowing becomes unsafe - Monitor weight and nutritional status 3. COMMUNICATION: - Speech therapy: voice banking (recording voice for future AAC devices) - Augmentative and Alternative Communication (AAC) devices (eye-tracking technology when patient cannot speak) - Allow extra time; do not finish sentences for the patient 4. MOBILITY AND SKIN: - Physical and occupational therapy for as long as possible - Adaptive equipment: braces, wheelchairs, environmental controls - Pressure injury prevention (position changes, pressure-relieving mattresses) 5. PSYCHOSOCIAL AND PALLIATIVE CARE: - ALS is a terminal illness — emotional support is essential - Facilitate advance directives (Advance Care Planning in Philippine context) - Hospice/palliative care referral - Support groups for patients and families - Address depression and anxiety 6. PREVENTION OF COMPLICATIONS: - Aspiration pneumonia (positioning, thickened liquids, PEG) - DVT/PE (compression stockings, early mobilization, anticoagulation as appropriate) - Contractures (ROM exercises) NANDA Nursing Diagnoses: - Ineffective Airway Clearance related to respiratory muscle weakness - Risk for Aspiration related to dysphagia - Impaired Physical Mobility related to progressive motor weakness - Impaired Verbal Communication related to dysarthria - Grieving related to terminal diagnosis

Examples

This tests the nurse's ability to prioritize in a complex terminal illness. Respiratory assessment is the top priority in ALS. The nurse must simultaneously address communication needs, nutrition/aspiration, and advance care planning.

Scenario

A 52-year-old male with ALS is admitted to the medical unit. He is alert and oriented, answering questions appropriately, but his speech is severely slurred and his arms are very weak. The respiratory therapist reports his vital capacity is decreasing. What are the nurse's priority assessments and interventions?

Solution

PRIORITY: Respiratory function. (1) Assess vital capacity, SpO2, respiratory rate and effort — respiratory failure is the leading cause of death in ALS. (2) Notify the physician of decreasing vital capacity. (3) Discuss non-invasive ventilatory support (BiPAP) with the team. (4) Ensure suction and oxygen are at the bedside. (5) Assess swallowing — if impaired, implement aspiration precautions and consult speech therapy and dietitian for PEG tube planning. (6) Establish a communication system (AAC device) as speech is severely impaired. (7) Initiate advance care planning discussion gently — document patient's wishes regarding ventilator and resuscitation.

This tests conceptual understanding of the ALS pathophysiology. The preserved sensation in ALS has major implications for nursing care — comfort and pain management remain essential even in advanced disease.

Scenario

A nursing student asks why a patient with ALS can still feel pain and discomfort even though they cannot move. How would you explain this?

Solution

ALS specifically destroys MOTOR NEURONS — the nerve cells that control voluntary movement. However, SENSORY NEURONS — the nerve cells that carry pain, touch, temperature, and other sensations to the brain — are NOT affected by ALS. This means patients with ALS have NORMAL sensation throughout their illness: they feel pain, touch, pressure, and temperature normally, even as they lose all ability to move. This makes comfort care and pain management critically important — the patient may be completely paralyzed but still experience full pain and discomfort.

Applications

Palliative care: ALS is a model disease for palliative and end-of-life care nursing
Respiratory therapy collaboration: BiPAP management, ventilator care
Communication technology: nurses must be familiar with AAC devices and communication strategies
Community/home health: supporting ALS patients and families as disease progresses in the home setting

Misconceptions

MYTH: ALS patients eventually lose their ability to think and feel. FACT: COGNITION and SENSATION are PRESERVED in most ALS patients. The patient fully understands their situation and feels everything.
MYTH: Riluzole cures ALS. FACT: Riluzole only modestly slows progression — there is NO cure. It extends life by approximately 2–3 months.
MYTH: ALS patients die from the primary disease in the brain. FACT: The cause of death is RESPIRATORY FAILURE due to progressive weakness of the breathing muscles.
MYTH: When a patient with ALS can no longer speak, they can no longer communicate. FACT: AAC devices (including eye-tracking technology) allow communication even when all other motor function is lost.

Related Concepts

Motor Neuron Disease
Respiratory Failure and Mechanical Ventilation
Palliative and End-of-Life Care
Dysphagia Management
Guillain-Barré Syndrome (comparison — motor-predominant, but peripheral and reversible)

Common Exam Questions

Example

What is the nurse's priority assessment for a patient with ALS? Answer: Monitoring respiratory function (vital capacity and SpO2).

Approach

In ALS, the priority is always RESPIRATORY — specifically vital capacity monitoring. Death comes from respiratory failure.

Question Type

Priority Nursing Assessment

Example

Which assessment finding would be UNEXPECTED in a patient with ALS? Answer: Loss of sensation (pain perception) — sensation is preserved in ALS.

Approach

Know what ALS does NOT affect: sensation, cognition (in most), eye movements, bowel/bladder (usually). What it DOES affect: all voluntary motor function.

Question Type

Preserved vs Affected Functions

Example

Which medication has been shown to modestly slow the progression of ALS? Answer: Riluzole (Rilutek).

Approach

Riluzole = the drug that modestly slows ALS progression. There is NO cure.

Question Type

Drug of Choice

Key Points To Remember

ALS = degeneration of MOTOR NEURONS only (upper and lower)
SENSATION, COGNITION, and EYE MOVEMENTS are PRESERVED (until very late)
Hallmark: FASCICULATIONS (visible muscle twitching) + progressive weakness + wasting
Death is from RESPIRATORY FAILURE — monitor vital capacity and respiratory function
RILUZOLE modestly slows progression — it is the cornerstone drug for ALS
No cure exists — management is SUPPORTIVE and PALLIATIVE
DYSPHAGIA → aspiration risk → PEG tube when swallowing is unsafe
Priority nursing assessment: RESPIRATORY FUNCTION (vital capacity)
Advance care planning is essential — discuss ventilator wishes early
Emotional lability (crying/laughing without control) = pseudobulbar affect, not psychiatric disorder
AAC devices preserve communication when speech is lost

Myasthenia Gravis and the Myasthenic vs Cholinergic Crisis Differential

Myasthenia Gravis (MG) is an autoimmune disorder in which the body produces antibodies against ACETYLCHOLINE RECEPTORS (AChR) at the NEUROMUSCULAR JUNCTION (NMJ). These antibodies block, destroy, and reduce the number of functional AChR sites, so acetylcholine released from the nerve terminal cannot effectively trigger muscle contraction. The result: FLUCTUATING MUSCLE WEAKNESS that is WORSE WITH ACTIVITY (fatigable weakness) and BETTER WITH REST. This fatiguability is pathognomonic (uniquely characteristic) of MG. Causes/Associations: - Thymic abnormalities in most MG patients: Thymoma (10–15%) or thymic hyperplasia (65–70%) - Autoimmune trigger CLINICAL MANIFESTATIONS: - PTOSIS (drooping of one or both eyelids) — often the FIRST and most visible sign - DIPLOPIA (double vision) — extraocular muscle weakness - DYSPHAGIA (difficulty swallowing) and DYSARTHRIA (slurred speech) — from bulbar muscle weakness - Weak, NASAL voice - Facial weakness — 'myasthenic snarl' (smile looks like a sneer) - Chewing fatigue (food left on the table half-eaten as muscles tire) - LIMB WEAKNESS — worse with repeated use, better after rest - RESPIRATORY MUSCLE WEAKNESS — the DANGER — can cause respiratory failure (myasthenic crisis) Key pattern: Weakness is WORSE LATER IN THE DAY (after sustained muscle use) and BETTER IN THE MORNING (after rest overnight). The patient who looks almost normal at 8 AM may be too weak to chew lunch by noon. DIAGNOSIS: - AChR ANTIBODY test: Positive in 85% of generalized MG patients; confirmatory - EDROPHONIUM (TENSILON) TEST: Short-acting anticholinesterase injected IV. In MG, this causes brief but DRAMATIC IMPROVEMENT in muscle strength (diagnostic); closely monitored for bradycardia and excess cholinergic effects during the test - Electromyography (EMG): Repetitive nerve stimulation shows DECREMENTAL response (muscle response decreases with each repeated nerve stimulation — classic for NMJ disorder) - CT/MRI chest: To detect thymoma PHARMACOLOGY: 1. PYRIDOSTIGMINE (Mestinon) — FIRST-LINE SYMPTOMATIC TREATMENT - Mechanism: Anticholinesterase — inhibits the enzyme that breaks down acetylcholine (acetylcholinesterase), so more acetylcholine accumulates at the NMJ and can interact with remaining receptors - IMPORTANT TIMING: Give 30–45 minutes BEFORE MEALS to maximize muscle strength for chewing and swallowing (prevents aspiration and choking) - Side effects: CHOLINERGIC effects (excess acetylcholine): DIARRHEA, abdominal cramps, excessive secretions (salivation, lacrimation), bradycardia 2. IMMUNOSUPPRESSANTS: Corticosteroids (prednisone), azathioprine, mycophenolate — for long-term immune suppression 3. THYMECTOMY: Surgical removal of the thymus; recommended for most MG patients under 60, especially those with thymoma; can lead to long-term remission or significant improvement 4. PLASMAPHERESIS (Plasma Exchange): Removes circulating AChR antibodies from the blood; rapid but temporary effect; used for crises and pre-surgical preparation 5. IV IMMUNOGLOBULIN (IVIG): Modulates immune response; rapid effect; used for crises --- CRITICAL DIFFERENTIAL: MYASTHENIC CRISIS vs CHOLINERGIC CRISIS This is one of the most heavily tested differentials in the entire NLE Neurosensory section. Both present with SEVERE WEAKNESS and RESPIRATORY FAILURE, but the cause and treatment are OPPOSITE. MYASTHENIC CRISIS: - Cause: TOO LITTLE anticholinesterase medication (undermedication), or trigger (infection, surgery, stress, certain drugs that block NMJ such as aminoglycosides) - Mechanism: Insufficient acetylcholine activity at the NMJ → severe muscle weakness - Clinical picture: Severe weakness, ptosis, dysphagia, respiratory failure WITHOUT excess cholinergic signs - Pupils: NORMAL or dilated (mydriasis) - No SLUDGE symptoms - Treatment: Give MORE anticholinesterase drug (pyridostigmine); may need plasmapheresis or IVIG; AIRWAY SUPPORT CHOLINERGIC CRISIS: - Cause: TOO MUCH anticholinesterase medication (overmedication/overdose) - Mechanism: Excess acetylcholine everywhere (at NMJ AND muscarinic receptors throughout the body) → muscle depolarization block (muscles paralyzed from overstimulation) + systemic cholinergic effects - Clinical picture: Severe weakness AND the SLUDGE symptoms: * S — SALIVATION (excessive drooling) * L — LACRIMATION (excessive tearing) * U — URINATION (urinary incontinence) * D — DEFECATION (diarrhea) * G — GI UPSET (abdominal cramps, nausea) * E — EMESIS (vomiting) Plus: MIOSIS (constricted pupils), bradycardia, bronchospasm, muscle FASCICULATIONS - Treatment: WITHHOLD anticholinesterase drug; give ATROPINE (muscarinic antagonist, the antidote); AIRWAY SUPPORT THE TENSILON (EDROPHONIUM) TEST — How to Differentiate: - Administer a small dose of edrophonium (a very short-acting anticholinesterase) - Result in MYASTHENIC CRISIS: IMPROVEMENT in strength (the added acetylcholine helps the underdosed NMJ) → confirms myasthenic crisis - Result in CHOLINERGIC CRISIS: WORSENING of weakness (even more acetylcholine makes the situation worse) → confirms cholinergic crisis IN BOTH CRISES: - PRIORITY ACTION = MAINTAIN AIRWAY and SUPPORT VENTILATION - Have mechanical ventilation ready - Have ATROPINE at the bedside (antidote for cholinergic crisis) - Monitor respiratory function closely Memory Trick: - Myasthenic crisis = 'My-strength-is-gone' (NEEDS more drug) - Cholinergic crisis = 'SLUDGE + weakness' (needs LESS drug, needs ATROPINE) - Tensilon test: IMPROVEMENT = Myasthenic; WORSENING = Cholinergic

Examples

The SLUDGE symptoms (drooling, diarrhea, urination, abdominal cramps) plus miosis clearly point to cholinergic crisis (excess ACh). The NLE may test this through symptom recognition and asking for the priority action and antidote.

Scenario

A patient with MG has been taking pyridostigmine. She is now found with severe weakness, pinpoint pupils (miosis), excessive drooling, diarrhea, and abdominal cramps. What type of crisis is this and what is the priority action?

Solution

This is a CHOLINERGIC CRISIS (too much pyridostigmine causing excess acetylcholine and SLUDGE symptoms + miosis). Priority actions: (1) MAINTAIN AIRWAY — position patient, suction secretions, prepare for intubation/mechanical ventilation as this is respiratory emergency. (2) HOLD the pyridostigmine — do not give more drug. (3) Administer ATROPINE as ordered — it is the antidote (blocks muscarinic receptors). (4) Notify physician immediately. (5) Continue close monitoring of respiratory function.

Infection is a common precipitant of myasthenic crisis. The absence of SLUDGE differentiates it from cholinergic crisis. Critically low vital capacity requires immediate ventilatory support — this is an emergency.

Scenario

A patient with MG had a respiratory tract infection last week and has now been admitted with severe weakness and inability to hold up her head. She is anxious but alert. Vital capacity is 0.8 L (critically low). She has no excessive secretions, no diarrhea. What crisis is this and how is it managed?

Solution

This is a MYASTHENIC CRISIS triggered by infection. Key findings: severe weakness WITHOUT cholinergic (SLUDGE) symptoms. PRIORITY: (1) AIRWAY — vital capacity of 0.8 L is critically low (normal >3 L); prepare for intubation and mechanical ventilation immediately. (2) Notify physician — the patient may need ICU transfer. (3) Administer anticholinesterase drug or increase dose as ordered. (4) Consider plasmapheresis or IVIG for acute management. (5) Treat the underlying infection. (6) Emotional support — the patient is anxious but cognizant of her deteriorating state.

Applications

Emergency nursing: recognizing and differentiating myasthenic vs cholinergic crisis
Medication safety: ensuring pyridostigmine is given on time and before meals; reporting signs of toxicity
Surgical nursing: thymectomy perioperative care; monitoring post-operatively for respiratory complications
Patient education: medication timing, avoiding triggers (infection, aminoglycosides, extreme heat, stress)

Misconceptions

MYTH: Both crises are managed the same way — give more anticholinesterase. FACT: In CHOLINERGIC crisis, giving more drug WORSENS the condition. You must STOP the drug and give ATROPINE.
MYTH: The priority in MG crises is to give medication first. FACT: AIRWAY and VENTILATORY SUPPORT is always the priority — without it, the patient will die before any drug can help.
MYTH: Myasthenic weakness means the muscle itself is diseased. FACT: The muscles are structurally normal — the problem is at the NEUROMUSCULAR JUNCTION (receptors are blocked/destroyed by antibodies).
MYTH: MG symptoms are constant. FACT: MG symptoms FLUCTUATE — better with rest, worse with activity and later in the day. This fluctuation is characteristic.

Related Concepts

Guillain-Barré Syndrome (comparison — both cause muscle weakness and respiratory failure)
Neuromuscular Junction Pharmacology
Atropine Pharmacology
Cholinergic vs Anticholinergic Drug Effects
Respiratory Monitoring and Mechanical Ventilation

Common Exam Questions

Example

A patient with MG presents with weakness, drooling, diarrhea, and miosis. This presentation is consistent with which crisis? Answer: Cholinergic crisis.

Approach

SLUDGE symptoms = cholinergic. No SLUDGE but severe weakness = myasthenic. Tensilon test: improvement = myasthenic; worsening = cholinergic.

Question Type

Crisis Differentiation (Most heavily tested in MG)

Example

Which medication is the antidote for a cholinergic crisis in a patient with myasthenia gravis? Answer: Atropine.

Approach

The antidote for cholinergic crisis (anticholinesterase overdose) is ATROPINE — a muscarinic blocker.

Question Type

Antidote Identification

Example

When should pyridostigmine be administered for optimal benefit in a patient with myasthenia gravis? Answer: 30–45 minutes before meals.

Approach

Pyridostigmine must be given BEFORE meals (30–45 minutes) so the patient has muscle strength to chew and swallow safely.

Question Type

Medication Timing

Key Points To Remember

MG = autoimmune attack on ACETYLCHOLINE RECEPTORS at the neuromuscular junction
Hallmark: weakness WORSE with activity, BETTER with rest (fatiguable weakness)
PTOSIS and DIPLOPIA are often the FIRST signs of MG
Give pyridostigmine 30–45 MINUTES BEFORE MEALS to prevent aspiration while eating
MYASTHENIC CRISIS = too LITTLE drug → Tensilon test IMPROVES strength
CHOLINERGIC CRISIS = too MUCH drug → SLUDGE symptoms + Tensilon WORSENS
ATROPINE is the antidote for cholinergic crisis
PRIORITY in BOTH crises: AIRWAY and VENTILATORY SUPPORT
Thymectomy can produce long-term remission — CT chest to rule out thymoma
AChR antibody test is confirmatory for MG
Certain drugs WORSEN MG: aminoglycosides, quinolones, beta-blockers, neuromuscular blockers — avoid these

Guillain-Barré Syndrome (GBS)

Guillain-Barré Syndrome (GBS) is an acute, potentially life-threatening autoimmune disorder in which the immune system attacks and demyelinates the PERIPHERAL NERVOUS SYSTEM (PNS) — the nerves outside the brain and spinal cord. It is the most common cause of acute flaccid paralysis worldwide. AETIOLOGY: GBS usually follows an infection by 2–4 weeks. The immune response triggered by the infection mistakenly attacks peripheral nerve myelin (molecular mimicry). - Most common preceding infections: Campylobacter jejuni (most common bacterial trigger — from contaminated food), Cytomegalovirus (CMV), Epstein-Barr Virus (EBV), Influenza, Zika virus - Post-vaccination GBS is rare but has been reported PATHOPHYSIOLOGY: Autoimmune attack on peripheral nerve myelin → demyelination → disruption of nerve signal conduction → ascending weakness and paralysis CLINICAL MANIFESTATIONS — CLASSIC PRESENTATION: - Begins with PARESTHESIAS (tingling, numbness) in the FEET and LEGS - Followed by ASCENDING SYMMETRIC WEAKNESS starting in the LEGS and progressing UPWARD - Pattern: lower limbs first → abdomen/trunk → upper limbs → respiratory muscles → cranial nerves (face, swallowing) - DIMINISHED or ABSENT DEEP TENDON REFLEXES (areflexia) — a hallmark sign - AUTONOMIC INSTABILITY: Blood pressure fluctuations, cardiac dysrhythmias, orthostatic hypotension, ileus, urinary retention — from autonomic nerve involvement; can be life-threatening - CRANIAL NERVE INVOLVEMENT: Facial weakness, diplopia, dysphagia - PAIN: Severe back and leg pain is common and often precedes weakness CRITICAL DANGER: As the paralysis ascends to the RESPIRATORY MUSCLES, the patient develops RESPIRATORY FAILURE — the primary cause of death in GBS. MILLER-FISHER VARIANT: A variant of GBS presenting with ataxia, areflexia, and ophthalmoplegia (eye muscle paralysis) — does NOT typically progress to respiratory failure DIAGNOSIS: - Lumbar puncture: Classic finding = ALBUMINOCYTOLOGIC DISSOCIATION — HIGH protein with NORMAL or only mildly elevated cell count (WBC). Very few cells, very high protein. - Nerve conduction studies/EMG: Slowed conduction velocity (demyelination) - Clinical findings: Symmetric ascending weakness + areflexia NURSING MANAGEMENT — PRIORITY MONITORING: 1. RESPIRATORY MONITORING — ABSOLUTE HIGHEST PRIORITY: - Monitor VITAL CAPACITY (FVC) every 2–4 hours - When FVC falls to 15–20 mL/kg (or absolute <1 L), anticipate intubation - Monitor SpO2, respiratory rate, use of accessory muscles - Have mechanical ventilator on standby - The nurse must report any deterioration in respiratory function IMMEDIATELY - 'Watch the breathing, not just the weakness' 2. CARDIAC AND AUTONOMIC MONITORING: - Continuous cardiac monitoring for dysrhythmias - Frequent blood pressure monitoring (autonomic instability causes wild BP swings) - Atropine available for severe bradycardia 3. SUPPORTIVE CARE: - PAIN MANAGEMENT: GBS is very painful; adequate analgesia is essential (opioids, gabapentin) - SKIN INTEGRITY: Pressure injury prevention (turn q2h, pressure-relieving mattress) - DVT PREVENTION: Sequential compression devices, anticoagulation - BOWEL AND BLADDER: Urinary catheter if retention; bowel program - NUTRITION: Enteral feeding if dysphagia - COMMUNICATION: If intubated or too weak to speak, establish alternative communication 4. PSYCHOLOGICAL SUPPORT: - GBS is terrifying — a previously healthy person can become completely paralyzed within days, while remaining fully conscious - Constant communication, reassurance, and honesty about the usually favorable prognosis - GBS is self-limiting — most patients recover TREATMENT: - PLASMAPHERESIS (Plasma Exchange): Removes circulating antibodies from the blood; most effective if started within 2 weeks of onset; first-line treatment - IV IMMUNOGLOBULIN (IVIG): Modulates the immune response; equally effective as plasmapheresis; easier to administer - CORTICOSTEROIDS: NOT effective in GBS (do NOT use — they may actually worsen outcomes) - Physical and occupational therapy during recovery phase PROGNOSIS: - GBS is usually SELF-LIMITING — most patients recover significantly over weeks to months - Recovery begins as remyelination occurs - 70–80% recover full function; some have residual weakness - Mortality: ~5% (usually from respiratory failure or complications) NANDA Nursing Diagnoses: - Ineffective Breathing Pattern related to ascending respiratory muscle paralysis - Risk for Aspiration related to cranial nerve involvement - Acute Pain related to nerve inflammation - Risk for Injury related to paralysis and autonomic instability - Anxiety related to sudden loss of motor function

Examples

GBS is the classic case of 'ascending paralysis after infection.' The NLE will ask for the priority assessment — it is ALWAYS respiratory function (vital capacity) in GBS.

Scenario

A 35-year-old patient who had diarrhea 3 weeks ago now presents with progressive weakness of both legs and is unable to climb stairs. He has no sensation loss but has decreased deep tendon reflexes in both lower extremities. What is the suspected diagnosis and what is the nurse's priority assessment?

Solution

The clinical picture is consistent with Guillain-Barré Syndrome: recent infection (Campylobacter diarrhea), followed 2–4 weeks later by ascending symmetric weakness with areflexia. The PRIORITY NURSING ASSESSMENT is RESPIRATORY FUNCTION — specifically vital capacity. As the weakness ascends, it can reach the respiratory muscles causing respiratory failure. The nurse should: (1) Measure and monitor vital capacity every 2–4 hours. (2) Monitor SpO2 and work of breathing. (3) Prepare for possible ICU transfer and mechanical ventilation. (4) Assess for autonomic instability (BP and cardiac rhythm monitoring).

This tests pharmacologic knowledge specific to GBS AND nursing professional responsibility under RA 9173. Questioning a potentially harmful order is a core nursing accountability.

Scenario

A patient with GBS is being treated. The physician orders IV corticosteroids. As the nurse preparing to administer this order, what action is appropriate?

Solution

The nurse should question this order. CORTICOSTEROIDS are NOT effective in GBS and may actually worsen outcomes. The standard treatments for GBS are PLASMAPHERESIS or IV IMMUNOGLOBULIN (IVIG). The nurse should: (1) Double-check the order with the physician. (2) Clarify the rationale — if ordered for a different indication (e.g., a separate comorbidity), ensure it is not the primary treatment for GBS. (3) Document the clarification. Under RA 9173, nurses have the professional responsibility to clarify unclear or potentially harmful orders before administration.

Applications

Intensive care unit nursing: ventilator management in GBS with respiratory failure
Rehabilitation nursing: supporting recovery with physical and occupational therapy
Pain management: complex pain syndromes in GBS requiring multimodal analgesia
Community health: food safety education to prevent Campylobacter jejuni infection

Misconceptions

MYTH: GBS is a form of MS because both involve demyelination. FACT: MS affects the CNS (central); GBS affects the PNS (peripheral). They are completely different diseases with different treatments.
MYTH: Corticosteroids should be given for GBS as they are for MS relapses. FACT: Corticosteroids are NOT beneficial for GBS and are actually associated with worse outcomes.
MYTH: GBS always causes permanent paralysis. FACT: GBS is usually self-limiting and most patients recover significantly — the prognosis is generally favorable with proper supportive care.
MYTH: Sensation is the main concern in GBS, not movement. FACT: The hallmark is MOTOR (weakness and areflexia); sensation may be mildly affected but the critical danger is respiratory failure from motor paralysis.

Related Concepts

Multiple Sclerosis (CNS demyelination comparison)
Myasthenia Gravis (both cause weakness + respiratory failure)
Respiratory Failure and Mechanical Ventilation
Plasmapheresis Procedure
Autonomic Nervous System Dysfunction

Common Exam Questions

Example

A patient with GBS has ascending weakness now involving the trunk. What is the nurse's priority assessment? Answer: Monitor respiratory function (vital capacity and SpO2).

Approach

In GBS, always: respiratory function (vital capacity) is the priority. Any scenario describing ascending weakness in GBS should have 'monitor respiratory function' as the priority action.

Question Type

Priority Assessment

Example

Lumbar puncture in a patient with GBS reveals very high protein with only 2 WBCs/mm3. This pattern is called? Answer: Albuminocytologic dissociation — characteristic of GBS.

Approach

GBS CSF finding = high protein, normal or near-normal WBC = albumino-cytologic dissociation. This is a classic lab finding question.

Question Type

CSF Finding

Example

Which treatment is contraindicated in Guillain-Barré Syndrome? Answer: Corticosteroids (not beneficial and may worsen GBS).

Approach

GBS treatment = plasmapheresis OR IVIG. NOT corticosteroids — this is a critical negative fact.

Question Type

Treatment Identification

Key Points To Remember

GBS = demyelination of PERIPHERAL nerves (NOT the CNS like MS)
Classic presentation: ASCENDING SYMMETRIC WEAKNESS starting in the LEGS moving UP
AREFLEXIA (absent deep tendon reflexes) is a hallmark finding
Preceded by infection 2–4 weeks earlier (Campylobacter jejuni most common bacterial cause)
PRIORITY NURSING ASSESSMENT: RESPIRATORY FUNCTION (vital capacity)
Death is from RESPIRATORY FAILURE as paralysis ascends to breathing muscles
CSF finding: HIGH protein, NORMAL WBC = albumino-cytologic dissociation
Treatment: PLASMAPHERESIS or IVIG (corticosteroids are NOT effective and may worsen)
GBS is usually SELF-LIMITING — most patients recover significantly
AUTONOMIC INSTABILITY: monitor BP and cardiac rhythm continuously
Pain is common and significant — needs adequate analgesia

Alzheimer's Disease and Dementia

Alzheimer's disease (AD) is the most common cause of dementia, accounting for 60–80% of all dementia cases. It is a progressive, irreversible neurodegenerative disorder characterized by the progressive loss of memory, cognition, judgment, personality, and eventually all functions of daily living. PATHOPHYSIOLOGY: Two hallmark pathological features: 1. BETA-AMYLOID PLAQUES: Abnormal deposits of protein fragments between nerve cells in the brain; disrupt cell-to-cell communication 2. NEUROFIBRILLARY TANGLES: Twisted fibers of tau protein inside nerve cells; interfere with nutrient transport within neurons These changes lead to progressive neuron death, particularly in the hippocampus (memory) and cortex. RISK FACTORS: - Age (most significant) — risk doubles every 5 years after age 65 - Genetic: APOE-e4 allele increases risk; familial AD (early onset) associated with presenilin gene mutations - Head trauma, cardiovascular disease, hypertension, diabetes, low education CLINICAL STAGES (Progressive Deterioration): STAGE 1 — EARLY (Mild): - Short-term memory loss — forgetting recent events, conversations, names - Getting lost in familiar places - Difficulty finding words - Subtle personality changes - Still able to perform most ADLs independently with some help - Insight may be intact — patient is aware of memory problems and may be distressed STAGE 2 — MIDDLE (Moderate): - Increasing memory loss — forgetting personal history, unable to recognize familiar people - Wandering behavior (elopement risk) - Confusion about time, place, and person - Behavioral changes: agitation, sundowning (increased confusion in the late afternoon/evening), depression, paranoia, hallucinations - Unable to manage ADLs independently — needs assistance with bathing, dressing, grooming - SUNDOWNING: Increased confusion, agitation, and behavioral disturbance in the late afternoon/evening; associated with circadian rhythm disruption STAGE 3 — LATE (Severe): - Loss of ability to recognize family members - Unable to communicate verbally - Complete dependence for all ADLs - Loss of bowel and bladder control (incontinence) - Dysphagia — aspiration risk - Immobility — high risk for pressure injuries, contractures, DVT - Susceptibility to infections (pneumonia, UTI) - Death usually from aspiration pneumonia, sepsis, or other complications PHARMACOLOGY: No cure; medications modestly slow cognitive decline: 1. CHOLINESTERASE INHIBITORS — For MILD TO MODERATE AD: - Donepezil (Aricept), Rivastigmine (Exelon), Galantamine (Reminyl) - Mechanism: Inhibit acetylcholinesterase → increase acetylcholine in the brain (AD is associated with ACh deficiency) - Side effects: Nausea, vomiting, diarrhea, anorexia (GI side effects most common) 2. MEMANTINE (Namenda) — For MODERATE TO SEVERE AD: - Mechanism: NMDA receptor antagonist — blocks excessive glutamate activity (glutamate excitotoxicity damages neurons) - Can be used ALONE or in COMBINATION with a cholinesterase inhibitor 3. LECANEMAB (Leqembi): New monoclonal antibody targeting beta-amyloid; FDA-approved 2023; may slow progression in early AD NURSING CARE: 1. SAFETY — HIGHEST PRIORITY: - WANDERING PREVENTION: ID bracelet, bed alarms, secured unit (locked doors), GPS tracking, 'Safe Return' programs - FALL PREVENTION: Remove hazards, low bed, non-slip surfaces, supervision - Kitchen and driving safety: Remove stove knobs, restrict driving 2. STRUCTURED ROUTINE: - Establish a consistent, simple, predictable daily schedule - Reduces anxiety and confusion - Perform ADLs at the same time each day 3. COMMUNICATION: - Use simple, short sentences; one instruction at a time - Speak slowly and clearly, face the patient directly - Validation therapy: Acknowledge the patient's feelings even if content is confused - Reality orientation: For mild stages — gently reorient to time, place, person - Do NOT argue with a patient experiencing hallucinations or delusions — redirect instead 4. NUTRITION: - Monitor weight and nutritional intake - Small, frequent meals; finger foods (easier to self-feed) - Aspiration precautions in later stages - PEG tube discussion for advanced disease (advance care planning) 5. SUNDOWNING MANAGEMENT: - Maintain bright lighting during the day; reduce environmental stimulation in the evening - Consistent bedtime routine - Avoid restraints (worsen agitation) - Identify and treat underlying causes (pain, UTI, constipation) 6. CAREGIVER SUPPORT: - Caregiving for AD is exhausting and emotionally draining - Assess for caregiver burnout - Refer to support groups, respite care services - Teach caregivers: communication strategies, safety measures, when to seek help DEMENTIA vs DELIRIUM — CRITICAL DIFFERENTIAL (Always Tested): DEMENTIA: - ONSET: Gradual (months to years) - COURSE: Chronic, PROGRESSIVE, IRREVERSIBLE - CONSCIOUSNESS: Alert (not clouded until very late) - REVERSIBLE? NO (in Alzheimer's and most dementias) - Caused by: Neurodegeneration, vascular damage DELIRIUM: - ONSET: ACUTE (hours to days) - COURSE: FLUCTUATING (waxing and waning consciousness) - CONSCIOUSNESS: Clouded, confused - REVERSIBLE? YES — if underlying cause is treated - Caused by: Infection, drugs, metabolic problems, pain, hypoxia Key NLE tip: A patient who suddenly becomes confused overnight after a urinary catheter was inserted likely has DELIRIUM from UTI — not dementia. Treat the cause and confusion may resolve. NANDA Nursing Diagnoses: - Chronic Confusion related to progressive neurodegeneration - Risk for Injury (Wandering, Falls) related to cognitive impairment - Self-Care Deficit related to progressive cognitive decline - Caregiver Role Strain related to 24-hour caregiving demands

Examples

Sundowning management tests therapeutic communication, environmental management, and safety skills. The key is to never argue — redirect and validate the emotion, not the content.

Scenario

An 80-year-old patient with known Alzheimer's disease becomes extremely agitated every evening after 5 PM, pacing the halls and insisting she needs to 'go home' even though she has lived in the facility for 2 years. How does the nurse manage this?

Solution

This is SUNDOWNING — a classic behavioral manifestation of Alzheimer's disease occurring in the late afternoon/evening. Management: (1) Do NOT argue or force reality — 'You ARE home' rarely helps and may increase agitation. (2) Redirect and validate: 'I can see you want to go somewhere — let me walk with you.' (3) Ensure the environment has BRIGHT LIGHTING during the day (reduces sundowning). (4) Maintain a CONSISTENT EVENING ROUTINE to signal the transition to nighttime. (5) Assess for pain, UTI, constipation, or other discomfort that may worsen agitation. (6) Ensure safety: secure exits, bed alarm, ID bracelet.

This is a classic NLE differential question. The key discriminator is ONSET: gradual = dementia; acute = delirium. The potentially reversible nature of delirium makes identifying and treating the cause critical.

Scenario

A nurse is assessing two patients: Patient A has been forgetting things progressively over 2 years and can no longer dress herself. Patient B was completely alert and oriented until last night when she suddenly became very confused, agitated, and disoriented. Patient B was found to have a fever of 38.5°C and foul-smelling urine. How would you differentiate these two presentations?

Solution

Patient A: Gradual onset (2 years), progressive, irreversible — consistent with DEMENTIA (likely Alzheimer's disease). Patient B: ACUTE onset (overnight), with fever and signs of UTI — this is DELIRIUM, likely caused by urinary tract infection. Key differences: DEMENTIA = gradual/progressive/irreversible; DELIRIUM = acute/fluctuating/reversible. Management: For Patient B, treat the UTI (antibiotics, adequate hydration) and the confusion should resolve. Always look for and treat reversible causes of acute confusion before assuming irreversible dementia.

Key Points To Remember

Alzheimer's = most common cause of dementia (60–80%)
Hallmark pathology: BETA-AMYLOID PLAQUES and NEUROFIBRILLARY TANGLES
Progressive: early (forgetfulness) → middle (wandering, sundowning) → late (total dependence)
Cholinesterase inhibitors (donepezil, rivastigmine, galantamine): for mild to moderate AD
Memantine (NMDA antagonist): for moderate to severe AD
SAFETY is the priority nursing concern: wandering prevention, fall prevention
SUNDOWNING: increased confusion in late afternoon/evening — maintain bright light in daytime
NEVER argue with a confused patient — redirect and validate feelings
Dementia = CHRONIC, GRADUAL, IRREVERSIBLE
Delirium = ACUTE, FLUCTUATING, REVERSIBLE (treat the cause!)
Caregiver support and burnout prevention are essential nursing roles in AD care

Previous chapter

Cerebrovascular Disorders and Increased Intracranial Pressure

Next chapter

Spinal Cord and Peripheral Nerve Disorders

Ready to practise for the NLE 2026?

Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target NLE exam date.

Start free See the full NLE guide NLE preparation guide

← Back to Neurosensory Nursing hub